Tag: regulatory guidelines
Special Populations in Bioequivalence: Age and Sex Considerations
Bioequivalence studies must now reflect real-world users. Age and sex differences impact how drugs work-regulators like the FDA now require balanced representation in generic drug testing to ensure safety and effectiveness for everyone.